El trading conlleva riesgos
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Dr Reddy's Laboratories Ltd-ADR
Abierto
SectorSalud
13.79 -1.22
Resumen
Variación precio
24h
Mínimo
13.58
Máximo
14.01
Ingresos | 1.5B 14B |
|---|---|
Ventas | 3.4B 84B |
P/B Media del Sector | 18.227 57.333 |
BPA | 16.936 |
Rentabilidad por dividendo | 0.7 |
Margen de beneficio | 16.795 |
Empleados | 27,048 |
EBITDA | 2.4B 24B |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 meses | +21.43% upside |
Rentabilidad por dividendo Media del Sector | 0.70% 2.63% |
|---|
Capitalización de Mercado | 9.1B 11B |
|---|---|
Apertura anterior | 15.01 |
Cierre anterior | 13.79 |
Puntuación técnica
By Trading Central
Confianza
Bullish Evidence
Dr Reddy's Laboratories Ltd-ADR Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Dr Reddy's Laboratories Ltd-ADR Esperado
Precio Objetivo
By TipRanks
21.43% repunte
Estimación a 12 meses
Media 17 USD 21.43%
Máximo 17 USD
Mínimo 17 USD
De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Dr Reddy's Laboratories Ltd-ADR Dist en los últimos 3 meses.
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Dr Reddy's Laboratories Ltd-ADR
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
